257 related articles for article (PubMed ID: 30460685)
1. Genetic risk score modifies the effect of APOE on risk and age onset of Alzheimer's disease.
Shi Z; Yu H; Wu Y; Ford M; Perschon C; Wang C; Zheng SL; Xu J
Clin Genet; 2019 Feb; 95(2):302-309. PubMed ID: 30460685
[TBL] [Abstract][Full Text] [Related]
2. The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study.
van der Lee SJ; Wolters FJ; Ikram MK; Hofman A; Ikram MA; Amin N; van Duijn CM
Lancet Neurol; 2018 May; 17(5):434-444. PubMed ID: 29555425
[TBL] [Abstract][Full Text] [Related]
3. A Weighted Genetic Risk Score Based on Four APOE-Independent Alzheimer's Disease Risk Loci May Supplement APOE E4 for Better Disease Prediction.
Zhang C; Hu R; Zhang G; Zhe Y; Hu B; He J; Wang Z; Qi X
J Mol Neurosci; 2019 Nov; 69(3):433-443. PubMed ID: 31346968
[TBL] [Abstract][Full Text] [Related]
4. A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42.
Sleegers K; Bettens K; De Roeck A; Van Cauwenberghe C; Cuyvers E; Verheijen J; Struyfs H; Van Dongen J; Vermeulen S; Engelborghs S; Vandenbulcke M; Vandenberghe R; De Deyn PP; Van Broeckhoven C;
Alzheimers Dement; 2015 Dec; 11(12):1452-1460. PubMed ID: 26086184
[TBL] [Abstract][Full Text] [Related]
5. [ACT/AA polymorphism could duplicate the APOE*epsilon4-associated Alzheimer's disease risk].
Hernández-Charro B; Moreno S; Valiente A; Manubens JM; Villar MD; Ramos-Arroyo MA
Med Clin (Barc); 2004 Sep; 123(7):251-4. PubMed ID: 15482730
[TBL] [Abstract][Full Text] [Related]
6. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis.
Agarwal R; Tripathi CB
Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):575-82. PubMed ID: 25551132
[TBL] [Abstract][Full Text] [Related]
7. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
Mattila KM; Rinne JO; Röyttä M; Laippala P; Pietilä T; Kalimo H; Koivula T; Frey H; Lehtimäki T
J Med Genet; 2000 Oct; 37(10):766-70. PubMed ID: 11015454
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive search for Alzheimer disease susceptibility loci in the APOE region.
Jun G; Vardarajan BN; Buros J; Yu CE; Hawk MV; Dombroski BA; Crane PK; Larson EB; ; Mayeux R; Haines JL; Lunetta KL; Pericak-Vance MA; Schellenberg GD; Farrer LA
Arch Neurol; 2012 Oct; 69(10):1270-9. PubMed ID: 22869155
[TBL] [Abstract][Full Text] [Related]
9. Risk prediction for sporadic Alzheimer's disease using genetic risk score in the Han Chinese population.
Xiao Q; Liu ZJ; Tao S; Sun YM; Jiang D; Li HL; Chen H; Liu X; Lapin B; Wang CH; Zheng SL; Xu J; Wu ZY
Oncotarget; 2015 Nov; 6(35):36955-64. PubMed ID: 26543236
[TBL] [Abstract][Full Text] [Related]
10. The SIRT2 polymorphism rs10410544 and risk of Alzheimer's disease in two Caucasian case-control cohorts.
Polito L; Kehoe PG; Davin A; Benussi L; Ghidoni R; Binetti G; Quadri P; Lucca U; Tettamanti M; Clerici F; Bagnoli S; Galimberti D; Nacmias B; Sorbi S; Guaita A; Scarpini E; Mariani C; Forloni G; Albani D
Alzheimers Dement; 2013 Jul; 9(4):392-9. PubMed ID: 22651940
[TBL] [Abstract][Full Text] [Related]
11. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
12. Polygenic risk scores in familial Alzheimer disease.
Tosto G; Bird TD; Tsuang D; Bennett DA; Boeve BF; Cruchaga C; Faber K; Foroud TM; Farlow M; Goate AM; Bertlesen S; Graff-Radford NR; Medrano M; Lantigua R; Manly J; Ottman R; Rosenberg R; Schaid DJ; Schupf N; Stern Y; Sweet RA; Mayeux R
Neurology; 2017 Mar; 88(12):1180-1186. PubMed ID: 28213371
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease.
Drigalenko E; Poduslo S; Elston R
Neurology; 1998 Jul; 51(1):131-5. PubMed ID: 9674791
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease genes and cognition in the nondemented general population.
Verhaaren BF; Vernooij MW; Koudstaal PJ; Uitterlinden AG; van Duijn CM; Hofman A; Breteler MM; Ikram MA
Biol Psychiatry; 2013 Mar; 73(5):429-34. PubMed ID: 22592056
[TBL] [Abstract][Full Text] [Related]
15. Contribution of APOE promoter polymorphisms to Alzheimer's disease risk.
Lambert JC; Araria-Goumidi L; Myllykangas L; Ellis C; Wang JC; Bullido MJ; Harris JM; Artiga MJ; Hernandez D; Kwon JM; Frigard B; Petersen RC; Cumming AM; Pasquier F; Sastre I; Tienari PJ; Frank A; Sulkava R; Morris JC; St Clair D; Mann DM; Wavrant-DeVrièze F; Ezquerra-Trabalon M; Amouyel P; Hardy J; Haltia M; Valdivieso F; Goate AM; Pérez-Tur J; Lendon CL; Chartier-Harlin MC
Neurology; 2002 Jul; 59(1):59-66. PubMed ID: 12105308
[TBL] [Abstract][Full Text] [Related]
16. Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease.
Wiebusch H; Poirier J; Sévigny P; Schappert K
Hum Genet; 1999 Feb; 104(2):158-63. PubMed ID: 10190327
[TBL] [Abstract][Full Text] [Related]
17. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease.
Coon KD; Myers AJ; Craig DW; Webster JA; Pearson JV; Lince DH; Zismann VL; Beach TG; Leung D; Bryden L; Halperin RF; Marlowe L; Kaleem M; Walker DG; Ravid R; Heward CB; Rogers J; Papassotiropoulos A; Reiman EM; Hardy J; Stephan DA
J Clin Psychiatry; 2007 Apr; 68(4):613-8. PubMed ID: 17474819
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
Hsiung GY; Sadovnick AD; Feldman H
CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
[TBL] [Abstract][Full Text] [Related]
19. Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.
Desikan RS; Fan CC; Wang Y; Schork AJ; Cabral HJ; Cupples LA; Thompson WK; Besser L; Kukull WA; Holland D; Chen CH; Brewer JB; Karow DS; Kauppi K; Witoelar A; Karch CM; Bonham LW; Yokoyama JS; Rosen HJ; Miller BL; Dillon WP; Wilson DM; Hess CP; Pericak-Vance M; Haines JL; Farrer LA; Mayeux R; Hardy J; Goate AM; Hyman BT; Schellenberg GD; McEvoy LK; Andreassen OA; Dale AM
PLoS Med; 2017 Mar; 14(3):e1002258. PubMed ID: 28323831
[TBL] [Abstract][Full Text] [Related]
20. APOE epsilon4 is a high-risk factor for Alzheimer's disease in the Mongolian population.
Huriletemuer ; Wang B; Wang J; Wang G; Zhang C; Zhao S; Zhou S; Ma X; Wang de S
J Neurol Sci; 2010 Jan; 288(1-2):167-9. PubMed ID: 19819468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
